Trifluridine/Tipiracil-Associated Neutropenia in Metastatic Colorectal Cancer: What It Means for Treatment Outcomes
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 10, 2026. n Metastatic colorectal cancer (mCRC) remains
Topic
Understanding Cancer
31 articles on Understanding Cancer, written for patients and carers arranging specialty treatment.
-
-
New Hope for Advanced Prostate Cancer: Enzalutamide and Radium-223 Combination Shows Survival Benefit
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 5, 2026. n Advances in prostate cancer treatment
-
Zongertinib Receives FDA Accelerated Approval for HER2+ NSCLC Treatment
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 28, 2026. n The U.S. Food and Drug
-
Targeted Therapy with Larotrectinib in NTRK Fusion Cancers: Results from the NCI-MATCH ECOG-ACRIN Trial
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 27, 2026. n Precision oncology has transformed cancer
-
FDA Gives Full Approval to Encorafenib Combo for BRAF V600E Metastatic Colorectal Cancer
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 26, 2026. n The US FDA has granted
-
Oral SERDs Explained: The New Hormone Therapy Option After Endocrine Resistance in HR+ Breast Cancer
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 25, 2026. n Hormone receptor-positive, HER2-negative breast cancer
-
New First-Line Option: FDA Approves Acalabrutinib Combo for CLL/SLL
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 24, 2026. n A new frontline treatment option
-
Venetoclax–Rituximab Retreatment in CLL: What a 100% Response Rate Means for Patients
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 23, 2026. n Chronic lymphocytic leukemia (CLL) treatment
-
Fixed-Duration Venetoclax vs Continuous Ibrutinib in Untreated CLL: What the CLL17 Trial Means for Patients
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026. n Chronic lymphocytic leukemia (CLL) is
-
Does Ribociclib Still Help After 3 Years? The NATALEE Trial’s 4-Year Follow-Up Answers
Medical Review: This article was reviewed by Dr. Sophie Reynolds on February 21, 2026. n For patients with hormone receptor–positive,
Still have a question?
We reply to every enquiry within one working day.